Patient Safety First – Particle reduction with ready-to-use vials in the entire value chain

Sterile injectable drugs play a crucial role in the treatment of disease. All stakeholders in this industry have the inherent goal to make injectable drugs safe and effective. This includes an expectation that every lot be essentially free from visible particulates, and that manufacturers strive to minimize all particulate and foreign contamination. In this Webinar, we reveal how we reduce particles in ready-to-use packaging by aligning lid material, adhesive and sealing parameters based on a scientific study performed in 2019.

Register for the SCHOTT ID and get access to SCHOTT Pharma exclusive content:

SCHOTT ID is your central key to valuable information and features related to our products and applications. Whether you are an interested party, customer, or partner, you can benefit from simplified access to extended content, practical tools, and digital offerings alongside our range of products.

Transparent.png